-+ 0.00%
-+ 0.00%
-+ 0.00%
Enterprise Value Research Institute> Analyst Report Summary: Takeda Pharmaceutical, KDDI, etc. Takeda Pharmaceutical's recent financial results show stable performance in the global market. The company is focusing on new drug development and market expansion. KDDI's earnings report indicates strong growth in mobile services and continued investment in network infrastructure. The company is also exploring new business opportunities in the digital sector.
Share

Please log in to view news

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending